Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS
暂无分享,去创建一个
[1] Jacob I. Ayers,et al. Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease , 2014, Journal of neurochemistry.
[2] D. Borchelt,et al. An Analysis of Interactions between Fluorescently-Tagged Mutant and Wild-Type SOD1 in Intracellular Inclusions , 2013, PloS one.
[3] D. Borchelt,et al. Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1 , 2013, Molecular Neurodegeneration.
[4] Olubunmi Abel,et al. Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD) , 2013, JMIR mHealth and uHealth.
[5] D. Borchelt,et al. A novel variant of human superoxide dismutase 1 harboring amyotrophic lateral sclerosis‐associated and experimental mutations in metal‐binding residues and free cysteines lacks toxicity in vivo , 2012, Journal of neurochemistry.
[6] D. Borchelt,et al. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states , 2011, Molecular Neurodegeneration.
[7] A. Al-Chalabi,et al. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[8] D. Borchelt,et al. Copper and Zinc Metallation Status of Copper-Zinc Superoxide Dismutase from Amyotrophic Lateral Sclerosis Transgenic Mice* , 2010, The Journal of Biological Chemistry.
[9] A. Hubbard,et al. Copper handling machinery of the brain. , 2010, Metallomics : integrated biometal science.
[10] J. Valentine,et al. Disrupted zinc-binding sites in structures of pathogenic SOD1 variants D124V and H80R. , 2010, Biochemistry.
[11] Lisa M. Miller,et al. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease , 2009, NeuroImage.
[12] D. Borchelt,et al. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.
[13] D. Borchelt,et al. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS , 2009, Proceedings of the National Academy of Sciences.
[14] L. Klomp,et al. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. , 2008, Biochemical Society transactions.
[15] Bryan F. Shaw,et al. Detergent-insoluble Aggregates Associated with Amyotrophic Lateral Sclerosis in Transgenic Mice Contain Primarily Full-length, Unmodified Superoxide Dismutase-1* , 2008, Journal of Biological Chemistry.
[16] Bryan F. Shaw,et al. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? , 2007, Trends in biochemical sciences.
[17] N. Lee,et al. Role of zinc in ALS , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[18] Antonio Lanzirotti,et al. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. , 2006, Journal of structural biology.
[19] H. Kozłowski,et al. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). , 2006, Chemical reviews.
[20] Bryan F. Shaw,et al. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Valentine,et al. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. , 2005, Annual review of biochemistry.
[22] Roberto Cappai,et al. Metals and amyloid‐β in Alzheimer's disease , 2005, International journal of experimental pathology.
[23] C. Griesinger,et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Selkoe,et al. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases , 2004, Nature Cell Biology.
[25] L. Bruijn,et al. Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.
[26] D. Selkoe. Folding proteins in fatal ways , 2003, Nature.
[27] Ashley I. Bush,et al. The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.
[28] V. Bindokas,et al. No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[29] Robert H. Brown,et al. Familial Amyotrophic Lateral Sclerosis-associated Mutations Decrease the Thermal Stability of Distinctly Metallated Species of Human Copper/Zinc Superoxide Dismutase* , 2002, The Journal of Biological Chemistry.
[30] Robert H. Brown,et al. Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis* 210 , 2002, The Journal of Biological Chemistry.
[31] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[32] T. O’Halloran,et al. Multiple Protein Domains Contribute to the Action of the Copper Chaperone for Superoxide Dismutase* , 1999, The Journal of Biological Chemistry.
[33] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[34] Xudong Huang,et al. Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors* , 1997, The Journal of Biological Chemistry.
[35] A. Doble. The pharmacology and mechanism of action of riluzole , 1996, Neurology.
[36] L. Ellerby,et al. Copper−Zinc Superoxide Dismutase: Why Not pH-Dependent? , 1996 .
[37] D. Borchelt,et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] 知弘 松山,et al. 虚血負荷後の海馬Copper-Zinc superoxide dismutase発現の検討 , 1994 .
[39] M. Pericak-Vance,et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.
[40] C. Soto,et al. Protein Misfolding in Neurodegenerative Diseases: The Key Pending Questions , 2013 .
[41] Claudio Soto,et al. Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.
[42] R. Miller,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[43] Patrik Brundin,et al. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. , 2002, Nature reviews. Neuroscience.